Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis

25 April 2025 : Clinical Research

İrfan Zengin

^{ABDEF 1*}, Mehmet Edip Akyol

^{ABDEFG 2}, Mustafa Arslan

^{ABF 3}, Özkan Arabacı^{ADF 2}, Eyyüp Yürektürk^{ADF 4}, Eyüp Çetin

^{ADEFG 5}, Halit Demir^{ACDE 6}

DOI: 10.12659/MSM.947873

Med Sci Monit 2025; 31:e947873

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions Rerefences

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Comparison of serum prolidase activity and IMA levels among NTD subtypes.

	Meningomyelocele	Meningocele	Myeloschisis	p value*
	(Mean±SD)	(Mean±SD)	(Mean±SD)	p value*
Prolidase activity (IU/L)	2.20±0.06	2.20±0.07	2.22±0.08	0.743
IMA (ABSUs)	0.40±0.01	0.41±0.01	0.40±0.02	0.631
^* Kruskal-Wallis test. IMA – ıschemia-modified albumin; IU/L – ınternational units per liter; ABSU – absorbance unit; SD – standard deviation.

Back to the Article